American Society for Neural Therapy and Repair
美国神经治疗与修复学会
基本信息
- 批准号:7672655
- 负责人:
- 金额:$ 2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-03-01 至 2010-02-28
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAmericanAwardBasic ScienceCollaborationsDirect CostsDisabled PersonsFloridaFundingHuntington DiseaseInstitutionLeadLearningMinorityNonprofit OrganizationsParkinson DiseasePostdoctoral FellowPrivate SectorPublic Health Applications ResearchRequest for ApplicationsResearchScientistSenior ScientistSocietiesSpinal cord injuryStrokeStudentsTraining and EducationTransplantationTraumatic Brain InjuryTravelUnited States National Institutes of HealthWomanWorkabstractingcostgene therapygraduate studentimprovedmeetingsnervous system disorderposterspublic health relevancerelating to nervous systemrepairedtreatment strategy
项目摘要
DESCRIPTION (provided by applicant): This R13 application seeks funding to support travel awards for students and postdoctoral fellows to attend the annual meeting of the American Society for Neural Therapy and Repair (ASNTR) 2009. Since its founding in 1994, the ASNTR has convened yearly each April/May in Clearwater, Florida. At the meeting various research advances in the fields of transplantation, neuroengineering and gene therapy applied to neurological diseases such as Parkinson's disease, Huntington's disease, Alzheimer's disease, stroke, spinal cord injury and traumatic brain injury are discussed via platform and poster presentations. ASNTR focuses on treatment strategies throughout all its sessions. Thus, students and postdoctoral fellows not only learn the basic sciences, they also learn translational issues discussed between basic scientists and clinicians. Therefore, ASNTR is truly a unique gathering. Attendance of this meeting ranges between 125-200 registrants. Each year the ASNTR Education and Training Committee encourages students/postdoctoral fellows to submit their abstracts in a competition and the top rated applicants receive travel awards to cover the cost of their meeting attendance and travel. ASNTR has always placed a high priority on funding travel awards for students and post-doctoral fellows. In the past ASNTR has received donations from biotech companies and non-profit organizations to cover these travel awards, However, in recent years ASNTR has seen these contributions dwindle and although ASNTR will continue to seek funding from the private sector, we do not anticipate any increase in contributions above recent levels in the coming years. Therefore NIH funding for this activity is critical. This application requests $20,000 in total direct costs to support travel awards for the top 20 graduate students/postdoctoral fellows from US institutions that apply (awards of $1000 per student/postdoc). ASNTR and the Education and Training Committee includes and encourages participation of women, minorities and persons with disabilities in all its activities. PUBLIC HEALTH RELEVANCE: This application seeks funding for travel awards for graduate students and postdocs to attend the annual meeting of the American Society for Neural Therapy and Repair. This meeting will allow young and senior scientists and doctors working to discover new treatments for neurological disorders to come together and discuss their new research findings. This meeting will potentially allow new research collaborations to occur that could lead to improved treatments.
描述(由申请人提供):本R13申请旨在资助学生和博士后参加2009年美国神经治疗和修复学会年会的旅行奖励。自1994年成立以来,ASNTR每年4月/ 5月在佛罗里达州克利尔沃特召开一次会议。在会议上,通过平台和海报展示讨论了移植、神经工程和基因治疗领域应用于帕金森病、亨廷顿病、阿尔茨海默病、中风、脊髓损伤和创伤性脑损伤等神经系统疾病的各种研究进展。ASNTR在其所有会议中都侧重于治疗策略。因此,学生和博士后不仅学习基础科学,他们还学习基础科学家和临床医生之间讨论的转化问题。因此,ASNTR确实是一次独特的聚会。出席本次会议的人数在125-200人之间。每年,ASNTR教育和培训委员会鼓励学生/博士后在竞赛中提交他们的摘要,排名最高的申请人将获得旅行奖励,以支付他们的会议出席和旅行费用。ASNTR一直高度重视资助学生和博士后研究员的旅行奖励。在过去,ASNTR收到了来自生物技术公司和非营利组织的捐款来支付这些旅行奖励,然而,近年来,ASNTR看到这些捐款减少了,尽管ASNTR将继续从私营部门寻求资金,但我们预计未来几年的捐款不会比最近的水平有所增加。因此,NIH对这项活动的资助至关重要。该申请要求总直接费用为20,000美元,用于支持申请美国机构的前20名研究生/博士后的旅行奖励(每名学生/博士后奖励1000美元)。残疾人协会和教育和培训委员会包括并鼓励妇女、少数民族和残疾人参与其所有活动。公共卫生相关:本申请为研究生和博士后参加美国神经治疗和修复学会年会寻求旅行奖励。这次会议将使致力于发现神经系统疾病新疗法的年轻和资深科学家和医生聚集在一起,讨论他们的新研究成果。这次会议将有可能促成新的研究合作,从而改善治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Caryl E Sortwell其他文献
Caryl E Sortwell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Caryl E Sortwell', 18)}}的其他基金
STN DBS Effects on Neuroinflammation and Degeneration Induced by Alpha-Synuclein Inclusions
STN DBS 对 α-突触核蛋白包涵体诱导的神经炎症和变性的影响
- 批准号:
10355915 - 财政年份:2021
- 资助金额:
$ 2万 - 项目类别:
The Rat Pre-Formed Alpha-Synuclein Fibril Model of Parkinson's Disease
帕金森病大鼠预制α-突触核蛋白原纤维模型
- 批准号:
9751424 - 财政年份:2018
- 资助金额:
$ 2万 - 项目类别:
The Rat Pre-Formed Alpha-Synuclein Fibril Model of Parkinson's Disease
帕金森病大鼠预制α-突触核蛋白原纤维模型
- 批准号:
9387180 - 财政年份:2017
- 资助金额:
$ 2万 - 项目类别:
American Society for Neural Therapy and Repair/International Conference on Neural
美国神经治疗与修复学会/国际神经会议
- 批准号:
8129235 - 财政年份:2011
- 资助金额:
$ 2万 - 项目类别:
Pleiotrophin Overexpression to Facilitate Repair and Graft Efficacy in Parkinsoni
多效蛋白过度表达促进帕金森病的修复和移植功效
- 批准号:
7447803 - 财政年份:2007
- 资助金额:
$ 2万 - 项目类别:
Pleiotrophin Overexpression to Facilitate Repair and Graft Efficacy in Parkinsoni
多效蛋白过度表达促进帕金森病的修复和移植功效
- 批准号:
7799276 - 财政年份:2007
- 资助金额:
$ 2万 - 项目类别:
Pleiotrophin Overexpression to Facilitate Repair and Graft Efficacy in Parkinsoni
多效蛋白过度表达促进帕金森病的修复和移植功效
- 批准号:
7246907 - 财政年份:2007
- 资助金额:
$ 2万 - 项目类别:
Pleiotrophin Overexpression to Facilitate Repair and Graft Efficacy in Parkinsoni
多效蛋白过度表达促进帕金森病的修复和移植功效
- 批准号:
8070414 - 财政年份:2007
- 资助金额:
$ 2万 - 项目类别:
Pleiotrophin Overexpression to Facilitate Repair and Graft Efficacy in Parkinsoni
多效蛋白过度表达促进帕金森病的修复和移植功效
- 批准号:
7591042 - 财政年份:2007
- 资助金额:
$ 2万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 2万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 2万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 2万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 2万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 2万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 2万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 2万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 2万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 2万 - 项目类别:














{{item.name}}会员




